The Role of Vitamin D in Cardiovascular Health-Linked Adipose Tissue
Keywords:
cardiovascular, Vitamin D, Adipose tissueAbstract
The rapid increase in the prevalence of cardiovascular diseases and low vitamin D levels are bothconsidered important public health issues. low level of vitamin D can promote endothelial dysfunction
and the development of atherosclerosis. also Vitamin D receptors are also expressed in the
cardiomyocytes of the left ventricle. One of the important mechanisms by which vitamin D affects
cardiovascular health is its effect on adipose tissue. Vitamin D can modulate the inflammatory response
of immune cells and adipocytes inside adipose tissue. Given the importance of vitamin D levels and
their relationship to adipose tissue in people with cardiovascular disease, understanding the mechanisms
of action of vitamin D in adipocytes may have a significant impact on maintaining cardiovascular health.
In the present review, we focus on mechanisms through which vitamin D may influence adipose tissue
associated with cardiovascular disease. In addition to checking whether vitamin D supplementation can
be a treatment option to improve adipose tissue function and thus prevent cardiovascular disease
References
-Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M. Modeling the burden of cardiovascular
diseases in Iran from 2005 to 2025: the impact of demographic changes. Iran J Public Health.
;46(4):506
-GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality
for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global
Burden of Disease Study 2017. Lancet 2018;392:1736–88.
- Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030.
PLoS Med. 2006;3(11):e442.
-Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019)
Results. Seattle, WA: Institute for Health Metrics and Evaluation (IHME); 2020.
- Mohammad AA, Rashad HH, Habeeb QS, Rashad BH and Saeed SY. Demographic, clinical and
angiographic profile of coronary artery disease in Kurdistan Region of Iraq. Am J Cardiovasc Dis. 2021;
(1): 39-45.
-Mendis S, Puska P, Norrving B, Organization WH. Global atlas on cardiovascular disease prevention
and control. Geneva: World Health Organization; 2011.
- Ofori EK, Intifu FD, Asante M, Asare GA, Adjei PK, Steele-Dadzie RK, et al. Prevalence of
cardiovascular disease risk factors among students of a tertiary institution in Ghana. Food Sci Nutr.
; 6: 381-387.
-Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, et al.
Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran.
;29:240.
- Ordovas JM. Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin
Nutr. 2006;83(2):443S–6S.
- Martirosyan DM, Miroshnichenko LA, Kulakova SN, Pogojeva AV, Zoloedov VI. Amaranth oil
application for coronary heart disease and hypertension. Lipids Health Dis. 2007;6(1):1.
- Després J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881.
- Pengpid S and Peltzer K. Overweight and Obesity among Adults in Iraq: Prevalence and Correlates
from a National Survey in 2015. Int. J. Environ. Res. Public Health 2021; 18, 4198.
- Cortese, F., Costantino, M.F., Luzi, G. et al. Vitamin D and cardiovascular disease risk. A literature
overview. Mol Biol Rep 49, 8925–8942 (2022).
-Kheiri, B., Abdalla, A., Osman, M. et al. Vitamin D deficiency and risk of cardiovascular diseases: a
narrative review. Clin Hypertens 24, 9 (2018).
-Holick, M.F. Sunlight, UV Radiation, Vitamin D, and Skin Cancer: How Much Sunlight Do We
Need? Adv. Exp. Med. Biol. 2020, 1268, 19–36.
-Mawer, E.B.; Backhouse, J.; Holman, C.A.; Lumb, G.A.; Stanbury, S.W. The distribution and
storage of vitamin D and its metabolites in human tissues. Clin. Sci. 1972, 43, 413–431.
- Latic, N.; Erben, R.G. Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension,
atherosclerosis, and Heart Failure. Int. J. Mol. Sci. 2020, 21, 6483.
-Institute of Medicine. Dietary Reference Intakes: Calcium and Vitamin D; National Academies
Press: Washington, DC, USA, 2011.
- Pilz, S.; Zittermann, A.; Trummer, C.; Theiler-Schwetz, V.; Lerchbaum, E.; Keppel, M.H.; Grübler,
M.R.; März, W.; Pandis, M. Vitamin D testing and treatment: A narrative review of current
evidence. Endocr. Connect. 2019, 8, R27–R43.
Munns CF, Shaw N, Kiely M, Specker BL, Thacher TD, Ozono K, Michigami T, Tiosano D,
Mughal MZ, Mäkitie O, Ramos-Abad L, Ward L, DiMeglio LA, Atapattu N, Cassinelli H, Braegger C,
Pettifor JM, Seth A, Idris HW, Bhatia V, Fu J, Goldberg G, Sävendahl L, Khadgawat R, Pludowski P,
Maddock J, Hyppönen E, Oduwole A, Frew E, Aguiar M, Tulchinsky T, Butler G, Högler W. Global
Consensus Recommendations on Prevention and Management of Nutritional Rickets. J Clin Endocrinol
Metab 2016;101:394-415. Epub 2016 Jan 8
-EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies). Scientific opinion on
dietary reference values for vitamin D. EFSA J. 2016, 14, 4547.
-DGE (German Nutrition Society), Österreichische Gesellschaft für Ernährung, Schweizerische
Gesellschaft für Ernährungsforschung, Schweizerische Vereinigung für Ernährung. D-A-CH
Referenzwerte für die Nährstoffzufuhr, 1st ed.; 5. korrigierter Nachdruck 2013; Neuer Umschau
Buchverlag: Neustadt an der Weinstraße, Germany, 2012.
-Nordic Council of Ministers. Nordic Nutrition Recommendations 2012, 5th ed.; Narayana Press:
Odder, Denmark, 2014.
-Nair R, Maseeh A. Vitamin D: The sunshine vitamin. J PharmacolPharmacother. 2012;3(2):118–26.
-Mohammed, Lina Y., et al. "The Prevalence of Vitamin D Deficiency and Associated Risk Factors
among General Populations in Duhok Province, Kurdistan Region, Iraq." J Contemp Med Sci| Vol 7.6
(2021): 330-333.
- A. M. Issa and S. A. Ibraheem, “Alterations of Vitamin “D” level in Sera of Iraqi Population,”
Journal of Kerbala University, vol. 5, no. 1, pp. 58-64, 2007].
-Mahdi M, Hantoosh H, Imran B, Yahya A. Prevalence of vitamin D deficiency in Iraqi female at
reproductive age. Medical Journal of Babylon.; 16(2) (2019
-Al-Alyani H, Al-Turki HA, Al-Essa ON, Alani FM, Sadat-Ali M. Vitamin D deficiency in Saudi
Arabians: A reality or simply hype: A meta-analysis (2008-2015). J Family Community Med.; 25(1):1-4
(2018).
- Hussein, Ibrahim Hani, et al. "Real-Life Data on Total Vitamin D3 (25-Hydroxyvitamin D)
Concentrations in Basrah, Iraq." Biomedical & Pharmacology Journal 14.4 (2021): 2191-2198.
-Hassan-Smith, Zaki K., Martin Hewison, and Neil J. Gittoes. "Effect of vitamin D deficiency in
developed countries." British medical bulletin 122.1 (2017): 79-89.
- Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, et al.
Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort
and randomised intervention studies. BMJ. (2014) 348:g1903. doi: 10.1136/bmj.g1903
- Gouni-Berthold, Ioanna, and Heiner K. Berthold. "Vitamin D and vascular disease." Current
vascular pharmacology 19.3 (2021): 250-268.
-Latic, N.; Erben, R.G. Vitamin D and Cardiovascular Disease, with Emphasis on Hypertension,
atherosclerosis, and Heart Failure. Int. J. Mol. Sci. 2020, 21, 6483.
-Norman, P.E.; Powell, J.T. Vitamin D and cardiovascular disease. Circ. Res. 2014, 114, 379–393.
-Condoleo, V.; Pelaia, C.; Armentaro, G.; Severini, G.; Clausi, E.; Cassano, V.; Miceli, S.; Fiorentino,
T.V.; Succurro, E.; Arturi, F.; et al. Role of Vitamin D in Cardiovascular Diseases. Endocrines 2021, 2,
-426.
-Chen, S.; Glenn, D.J.; Ni, W.; Grigsby, C.L.; Olsen, K.; Nishimoto, M.; Law, C.S.; Gardner, D.G.
Expression of the vitamin D receptor is increased in the hypertrophic heart. Hypertension 2008, 52,
–1112.
- Zittermann, A.; Schleithoff, S.S.; Tenderich, G.; Berthold, H.K.; Körfer, R.; Stehle, P. Low vitamin
D status: A contributing factor in the pathogenesis of congestive heart failure? J. Am. Coll. Cardiol.
, 41, 105–112.
-Chanakul, A.; Zhang, M.Y.H.; Louw, A.; Armbrecht, H.J.; Miller, W.L.; Portale, A.A.; Perwad, F.
FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues. PLoS ONE 2013, 8,
e72816.
-Somjen, D.; Weisman, Y.; Kohen, F.; Gayer, B.; Limor, R.; Sharon, O.; Jaccard, N.; Knoll, E.; Stern,
N. 25-Hydroxyvitamin D3-1-Hydroxylase Is Expressed in Human Vascular Smooth Muscle Cells and Is
Upregulated by Parathyroid Hormone and Estrogenic Compounds. Circulation 2005, 111, 1666–1671.
-Scialla, J.J.; Wolf, M. Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.
Nat. Rev. Nephrol. 2014, 10, 268–278.
-Schmidt, N.; Brandsch, C.; Kühne, H.; Thiele, A.; Hirche, F.; Stangl, G.I. Vitamin D receptor
deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in
mice. PLoS ONE 2012, 7, e35316
-Schmidt, N.; Brandsch, C.; Schutkowski, A.; Hirche, F.; Stangl, G.I. Dietary vitamin D inadequacy
accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor
knockout and wild-type mice. J. Nutr. 2014, 144, 638–646.
Mutt SJ, Hyppönen E, Saarnio J, Järvelin MR, Herzig KH. Vitamin D and adipose tissue-more than
storage. Front Physiol 2014;5:228.
- Nimitphong, Hataikarn, Eunmi Park, and Mi-Jeong Lee. "Vitamin D regulation of adipogenesis and
adipose tissue functions." Nutrition research and practice 14.6 (2020): 553.
-Park, C.Y.; Han, S.N. The role of vitamin D in adipose tissue biology: Adipocyte differentiation,
energy metabolism, and inflammation. J. Lipid Atheroscler. 2021, 10, 130.
-Yuzbashian, E.; Asghari, G.; Hedayati, M.; Zarkesh, M.; Mirmiran, P.; Khalaj, A. Determinants of
vitamin D receptor gene expression in visceral and subcutaneous adipose tissue in non-obese, obese, and
morbidly obese subjects. J. Steroid Biochem. Mol. Biol. 2019, 187, 82–87.
-Rosenstreich, S.J.; Rich, C.; Volwiler, W. Deposition in and release of vitamin D 3 from body fat:
Evidence for a storage site in the rat. J. Clin. Investig. 1971, 50, 679–687.
Clemente-Postigo M, Muñoz-Garach A, Serrano M, Garrido-Sánchez L, Bernal-López MR,
Fernández-García D, Moreno-Santos I, Garriga N, Castellano-Castillo D, Camargo A, Fernández-Real
JM, Cardona F, Tinahones FJ, Macías-González M. Serum 25-hydroxyvitamin D and adipose tissue
vitamin D receptor gene expression: relationship with obesity and type 2 diabetes. J Clin Endocrinol
Metab 2015;100:E591-5.
- Płudowski, P.; Kos-Kudła, B.; Walczak, M.; Fal, A.; Zozulińska-Ziółkiewicz, D.; Sieroszewski, P.;
Peregud-Pogorzelski, J.; Lauterbach, R.; Targowski, T.; Lewiński, A. Guidelines for preventing and
treating vitamin D deficiency: A 2023 update in Poland. Nutrients 2023, 15, 695.
-Szymczak-Pajor, I.; Miazek, K.; Selmi, A.; Balcerczyk, A.; Śliwińska, A. The action of vitamin D in
adipose tissue: Is there the link between vitamin D deficiency and adipose tissue-related metabolic
disorders? Int. J. Mol. Sci. 2022, 23, 956.
-Gangloff, A.; Bergeron, J.; Lemieux, I.; Després, J.-P. Changes in circulating vitamin D levels with
loss of adipose tissue. Curr. Opin. Clin. Nutr. Metab. Care 2016, 19, 464–470.
-Didriksen, A.; Burild, A.; Jakobsen, J.; Fuskevåg, O.M.; Jorde, R. Vitamin D3 increases in
abdominal subcutaneous fat tissue after supplementation with vitamin D3. Eur. J. Endocrinol. 2015, 172,
–241.
-Martinaityte, I.; Kamycheva, E.; Didriksen, A.; Jakobsen, J.; Jorde, R. Vitamin D stored in fat tissue
during a 5-year intervention affects serum 25-hydroxyvitamin D levels the following year. J. Clin.
Endocrinol. Metab. 2017, 102, 3731–3738.
-da Silva, E.M.S.; Pinho, H.S.; Rodrigues, I.G.; Pinho, C.P.S. Asociación entre los niveles séricos de
vitamina D y las alteraciones cardiometabólicas. Nutr. Clínica Dietética Hosp. 2019, 39, 86–93.
-da Silva, S.; Maria, E.; Pinho; Sabino, H.; Rodrigues; Galvão1, I.; Pinho; Sabino, C.P. Association
between serum vitamin D levels and cardiometabolic alterations. Nutr. Clín. Diet. Hosp. 2019, 39, 86–
-Carrelli, A.; Bucovsky, M.; Horst, R.; Cremers, S.; Zhang, C.; Bessler, M.; Schrope, B.; Evanko, J.;
Blanco, J.; Silverberg, S.J. Vitamin D storage in adipose tissue of obese and normal weight women. J.
Bone Miner. Res. 2017, 32, 237–242.
-Wortsman, J.; Matsuoka, L.Y.; Chen, T.C.; Lu, Z.; Holick, M.F. Decreased bioavailability of vitamin
D in obesity. Am. J. Clin. Nutr. 2000, 72, 690–693.
-Hey, H.; Stokholm, K.; Lund, B.; Sørensen, O. Vitamin D deficiency in obese patients and changes
in circulating vitamin D metabolites following jejunoileal bypass. Int. J. Obes. 1982, 6, 473–479.
-de Souza, Wysllenny Nascimento, and Ligia Araujo Martini. "The role of Vitamin D in obesity and
inflammation at adipose tissue." J Obes Metab Res 2.3 (2015): 161.
- Ching S, Kashinkunti S, Niehaus MD, Zinser GM. Mammary adipocytes bioactivate 25
hydroxyvitamin D3 and signal via Vitamin D3 receptor, modulating mammary epithelial cell growth. J
Cell Biochem 2011;112:3393 405
-Park JE, Pichiah PBT, Cha YS. Vitamin D and Metabolic Diseases: Growing Roles of Vitamin D. J
Obes Metab Syndr. 2018 Dec;27(4):223-232. doi: 10.7570/jomes.2018.27.4.223. Epub 2018 Dec 30.
PMID: 31089567; PMCID: PMC6513299.
-Han TS, Lean ME. A clinical perspective of obesity, metabolic syndrome and cardiovascular disease.
JRSM Cardiovasc Dis. 2016;5:2048004016633371. doi:10.1177/2048004016633371.
- Soskić, Sanja, Edita Stokić, and Esma R. Isenović. "The relationship between vitamin D and
obesity." Current medical research and opinion 30.6 (2014): 1197-1199.
-Ouellet, V., Labbe´ , S.M., Blondin, D.P., Phoenix, S., Gue´ rin, B., Haman, F., Turcotte, E.E.,
Richard, D., and Carpentier, A.C. (2012). Brown adipose tissue oxidative metabolism contributes to
energy expenditure during acute cold exposure in humans. J. Clin. Invest. 122, 545–552.
- Szymczak-Pajor, I.; Miazek, K.; Selmi, A.; Balcerczyk, A.; Śliwińska, A. The Action of Vitamin D
in Adipose Tissue: Is There the Link between Vitamin D Deficiency and Adipose Tissue-Related
Metabolic Disorders? Int. J. Mol. Sci. 2022, 23, 956
- Chiang, Janet M; Stanczyk, F. Z. (2018). Vitamin D Levels, Body Composition, and Metabolic
Factors in Asian Indians: Results from the Metabolic Syndrome and Atherosclerosis in South Asians
Living in America Pilot Study. (Thesis).
- Ferira, Ashley Jordan. Vitamin D, insulin sensitivity, and cardiometabolic risk in children. Diss.
University of Georgia, 2011.
-Pelczynska M, Grzelak T, Walczak M, Czyzewska K. Hypovitaminosis D and adipose tissue—cause
and effect relationships in obesity. Ann Agric Environ Med. 2016;23(3):403–9. pmid:27660858.
-Ding C, Gao D, Wilding J, Trayhurn P, Bing C. Vitamin D signalling in adipose tissue. Br J Nutr.
;108(11):1915–23. pmid:23046765.
-Wamberg L, Christiansen T, Paulsen SK, Fisker S, Rask P, Rejnmark L, et al. Expression of vitamin
D-metabolizing enzymes in human adipose tissue—the effect of obesity and diet-induced weight loss.
Int J Obes (Lond). 2013;37(5):651–7. pmid:22828938.
-Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in
obesity. Am J Clin Nutr. 2000;72(3):690–3. pmid:10966885.
-Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res. 2014;114(2):379–93.
pmid:24436433.
- Moukayed, Meis, and William B. Grant. "Linking the metabolic syndrome and obesity with vitamin D status:
risks and opportunities for improving cardiometabolic health and well-being." Diabetes, Metabolic Syndrome and
Obesity: Targets and Therapy (2019): 1437-1447.
- Zittermann, Armin, et al. "Vitamin D and cardiovascular disease: an updated narrative review." International
journal of molecular sciences 22.6 (2021): 2896.
-Elkhwanky MS, Kummu O, Piltonen TT, et al. Obesity represses CYP2R1, the vitamin D 25-hydroxylase, in
the liver and extrahepatic tissues. JBMR Plus. 2020;4(11):e10397. doi:10.1002/jbm4.10397
-Tobias, Deirdre K., et al. "Association of body weight with response to vitamin D supplementation and
metabolism." JAMA Network Open 6.1 (2023): e2250681-e2250681
Downloads
Published
Issue
Section
License
Copyright (c) 2024 University of Thi-Qar Journal Of Medicine
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
